RWE Refined: Novel Uses Across the Pharma Value Chain
When: Tuesday, 13 April 2021
Time: 10:00 NY / 14:00 London / 15:00 Paris
Whether it’s been in direct aid to vaccine development, COVID-19 treatment, or healthcare decision-making itself - the list of lessons learnt from the pandemic continues to grow each passing day. Few teachings have been as clear as how essential progress in the use of real-world evidence (RWE) across the value chain is for the successful transition to a digitally enabled, value-driven healthcare system.
From improving trial efficiency with novel design approaches and identifying unmet need in R&D, to enabling outcomes-based pricing agreements, providing real-time insights to HCPs and providing more strategic insights to enhance decision-making across the value chain – the list of how RWE is being applied is growing equally as long.
In our latest webinar we’re bringing together RWE leaders to share insight on how advances in analytics, data quality and collection, interoperability and new collaborations are further enabling RWE’s value.
Key learnings include:
- Use cases of RWE across the value chain, R&D to commercial
- How the RWD collection process has been impacted by COVID-19
- The capabilities and organisational set-up needed to enable effective use of RWE cross-functionally
- How to educate internal and external stakeholders on the value of RWE
Global Head Real World Science & Digital
Global Head of Development Real World Evidence
Cegedim Health Data
Source: Reuters Events